Biggest News Aggregation in the World
📰 Nasdaq Algs News

Nasdaq Algs News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Algs. Real-time updates on events, politics, business and more.

Short Interest in Aligos Therapeutics, Inc. (NASDAQ:ALGS) Increases By 6.4%

Aligos Therapeutics, Inc. (NASDAQ:ALGS – Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 894,500 shares, a growth of 6.4% from the January 15th total of 840,400 shares. Based on an average daily volume of 294,500 shares, […]
Topco Ltd Prelude Capital Management Mirabella Financial Services Charles Schwab Investment Management Inc Aligos Therapeutics Inc Aligos Therapeutics

Critical Analysis: Aligos Therapeutics (NASDAQ:ALGS) versus INmune Bio (NASDAQ:INMB)

Aligos Therapeutics (NASDAQ:ALGS – Get Free Report) and INmune Bio (NASDAQ:INMB – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings. Risk and Volatility Aligos Therapeutics has a […]
United States South San Francisco Boca Raton Inmune Bio Katholieke Universiteit Leuven Emory University

Aligos Therapeutics (NASDAQ:ALGS) versus INmune Bio (NASDAQ:INMB) Financial Contrast

Aligos Therapeutics (NASDAQ:ALGS – Get Free Report) and INmune Bio (NASDAQ:INMB – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, risk, dividends, institutional ownership and profitability. Volatility and Risk Aligos Therapeutics has a […]
Boca Raton United States South San Francisco Katholieke Universiteit Leuven Inmune Bio Xencor Inc

Aligos Therapeutics (NASDAQ:ALGS) & LadRx (OTCMKTS:CYTR) Head-To-Head Analysis

Aligos Therapeutics (NASDAQ:ALGS – Get Free Report) and LadRx (OTCMKTS:CYTR – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, profitability, institutional ownership, dividends and valuation. Risk and Volatility Aligos Therapeutics has a beta […]
United States South San Francisco Katholieke Universiteit Leuven Los Angeles Luxna Biotech Co Ltd Aligos Therapeutics Inc

Critical Analysis: Aligos Therapeutics (NASDAQ:ALGS) & Vigil Neuroscience (NASDAQ:VIGL)

Aligos Therapeutics (NASDAQ:ALGS – Get Rating) and Vigil Neuroscience (NASDAQ:VIGL – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, valuation, dividends, risk and profitability. Profitability This table compares Aligos Therapeutics and Vigil Neuroscience’s […]
United States South San Francisco United Kingdom Katholieke Universiteit Leuven Vigil Neuroscience Inc Aligos Therapeutics Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Comparing Aligos Therapeutics (NASDAQ:ALGS) and Caribou Biosciences (NASDAQ:CRBU)

Aligos Therapeutics (NASDAQ:ALGS – Get Rating) and Caribou Biosciences (NASDAQ:CRBU – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk and institutional ownership. Profitability This table compares Aligos Therapeutics and Caribou Biosciences’ […]
United States South San Francisco Katholieke Universiteit Leuven Emory University Luxna Biotech Co Ltd Abbvie Manufacturing Management Unlimited Company
Source: wkrb13.com

Texas Pacific Land (NYSE:TPL) Shares Gap Down to $1,573.01

Aligos Therapeutics (NASDAQ:ALGS – Get Rating) is scheduled to be releasing its earnings data after the market closes on Thursday, May 4th. Analysts expect Aligos Therapeutics to post earnings of ($0.47) per share for the quarter. Aligos Therapeutics (NASDAQ:ALGS – Get Rating) last issued its quarterly earnings results on Thursday, March 9th. The company reported […]
Piper Sandler Aligos Therapeutics Inc Topco Ltd Jefferies Financial Group Mirabella Financial Services Prelude Capital Management

Aligos Therapeutics, Inc. (NASDAQ:ALGS) Receives Average Recommendation of "Hold" from Analysts

Aligos Therapeutics, Inc. (NASDAQ:ALGS – Get Rating) has received an average rating of “Hold” from the six analysts that are covering the stock, Marketbeat reports. Five research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1 year price objective among brokerages that […]
United States Piper Sandler Aligos Therapeutics Inc Morgan Stanley Aligos Therapeutics Company Profile Get Rating Zacks Investment Research

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science